Molexis works alongside your team across the whole journey — market research, patent and legal strategy, deformulation, formulation experiments, and the regulatory dossier.
// Across the whole process
Where the opportunity is, and who's already there.
Freedom-to-operate, with a route around every claim.
The reference Q1/Q2 blueprint, from public filings.
IID-clear designs, bioequivalence read up front.
A cited, review-ready package for the regulator.
// Your data
Bring your own experimental records, formulation notes, or proprietary studies. Molexis learns from what you feed it and applies that context to every recommendation it makes — getting sharper the more you use it.
A generic is a copy in name only. The hard part — the patents, the chemistry, the filings — is years of reading. Molexis does that reading, and hands your scientists a head start.